Product Image

Ginkgo Biloba 60 mg

NOW
4.8
★ ★ ★ ★ ★
(3857 ratings)
Ginkgo
Product Image
Score83
A modest ginkgo serving for circulation-related cognitive use. Flavone and terpene marker groups are named, but their percentages and a purity limit are missing.
How scoring works
Quantity:240 Capsule(s) • (240 servings)
Goals:
Brain Health
Cognitive Support

Score 83

A modest ginkgo serving for circulation-related cognitive use. Flavone and terpene marker groups are named, but their percentages and a purity limit are missing.
How scoring works
$6.99($0.02 per serving)
Daily Vita
$ 20.80
iHerb
$ 22.04
Vitacost
$ 21.37
Amazon
$ 6.99
Report prices

Analysis

The capsule provides 60 mg ginkgo extract plus additional leaf material, targeting cerebral and peripheral circulation. The amount is better suited to light maintenance than a strong standalone regimen.

Ginkgo may support selected memory, focus, or circulation-related outcomes, but it is not a broad nootropic. Its vision relevance is also narrow because it does not supply lutein, zeaxanthin, retinal omega-3 fats, or antioxidant minerals.

Flavone and terpene marker groups are named, but their percentages and a purity limit are missing. The added 200 mg leaf powder increases raw plant material without confirming active strength. The focused format is easy to understand, though extract quality matters more than raw leaf weight or package size.

Who is it for
  • Adults seeking focused ginkgo supplementation
  • Users interested in circulation-related cognitive support
  • People who prefer a capsule
Best for
  • Targeted ginkgo use
  • Memory and focus routines in suitable adults
  • Users seeking a single-botanical formula

Pros

  • Ginkgo amount is clearly listed
  • Focused formula is easy to assess
  • Modest amount may suit light maintenance
  • Stimulant-free botanical

Cons

  • Does not provide broad cognitive pathway coverage
  • Not a complete vision formula
  • Extract standardization is incomplete
  • The added 200 mg leaf powder increases raw plant material without confirming active strength.

Warnings

  • Ginkgo may add to warfarin, direct oral anticoagulants, aspirin, or other antiplatelet effects and increase bleeding risk
  • Stop ginkgo before surgery or an invasive procedure when directed by the treating clinician because of its bleeding effects
  • Ginkgo may cause headache, dizziness, or digestive upset in sensitive users

Nutrient quality

84 Highest impact

The maintenance extract and additional leaf powder provide a meaningful ginkgo serving. Missing marker percentages and unstandardized powder limit consistency despite the coherent formula.

.

Ingredient transparency

80 High impact

Active amounts and marker names are disclosed without a hidden blend. Marker percentages, daily-use directions, and non-active ingredients remain unavailable.

.

Customer satisfaction

70 High impact

The available rating is strong and the sample is large. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

97 Highest impact

A meaningful serving and very long supply deliver excellent practical value. Incomplete standardization is the main trade-off, while unnecessary extras do not inflate the cost.

.
Report analysis

Goals

Brain Health
Impact
High effect
B+ Goal FitC+ Strength of SupportC CoverageA- Formula Quality

Ginkgo extract may support cerebral circulation and cognitive function, while added leaf powder broadens the botanical amount. The extract portion reaches a maintenance-level serving.

Marker groups are named without percentages, so standardized active yield cannot be confirmed. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Impact
High effect
A- Goal FitC Strength of SupportD CoverageB Formula Quality

Ginkgo directly supports cerebral circulation, giving the formula clear relevance to memory and attention. The extract amount fits maintenance use, while added leaf powder broadens the total ginkgo content.

Marker compounds are named without their percentages, so active potency and consistency cannot be confirmed. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines or when used near surgery.

Study evidence
Ginkgo Supportive 87 studies
Vision Support
Impact
Moderate effect
D Goal FitC+ Strength of SupportF CoverageB+ Formula Quality

Ginkgo may support ocular circulation but does not supply macular pigment, retinal lipids, or core antioxidant nutrients. The extract names both major marker groups but omits their percentages.

Added leaf powder broadens the amount without confirming active strength. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies
Productivity Boost
Impact
Moderate effect
C Goal FitC- Strength of SupportF CoverageB- Formula Quality

Ginkgo may support mental clarity through cerebral circulation, but the effect is generally modest and not an acute stimulant response. Human evidence is mixed and depends on well-standardized extracts, which the supplied label does not fully establish.

The 60 mg extract is a maintenance-level amount and is supplemented with unstandardized leaf powder. The focused ginkgo design is logical, but ginkgo may raise bleeding risk with anticoagulants, antiplatelet medicines, or around surgery.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mental Focus
Impact
Moderate effect
C- Goal FitC- Strength of SupportF CoverageB Formula Quality

Ginkgo may offer modest support for attention and processing, especially in some older adults. Evidence for a noticeable focus benefit in healthy younger users is less consistent.

The extract portion is modest and the marker groups are named, but their percentages are not provided. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per serving
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
60 mg
Ginkgo powder
200 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Women Vegetarian
Report overview
D- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value

The formula names both key extract marker groups but omits their percentages. Its extract portion fits a maintenance dose and is supplemented with unstandardized leaf powder. The cost per reference extract amount is very favorable. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  4. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledMental Focus forGinkgo
  5. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  6. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  7. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  8. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  9. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  10. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  11. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  12. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  13. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  14. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  15. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  16. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  17. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  18. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  19. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  20. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  21. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  22. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  23. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  24. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  25. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  26. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  27. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  28. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  29. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo